T. Daniels

2.6k total citations
35 papers, 1.1k citations indexed

About

T. Daniels is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, T. Daniels has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in T. Daniels's work include Cystic Fibrosis Research Advances (25 papers), Asthma and respiratory diseases (7 papers) and Tracheal and airway disorders (6 papers). T. Daniels is often cited by papers focused on Cystic Fibrosis Research Advances (25 papers), Asthma and respiratory diseases (7 papers) and Tracheal and airway disorders (6 papers). T. Daniels collaborates with scholars based in United Kingdom, United States and Australia. T. Daniels's co-authors include Geraint B. Rogers, Mary P. Carroll, Kenneth D. Bruce, Franziska A. Stressmann, Chris Gast, Julian Parkhill, Alan W. Walker, Lucas R. Hoffman, Benjamin Forbes and Nilesh Patel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Applied Physiology.

In The Last Decade

T. Daniels

31 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Daniels United Kingdom 15 671 479 182 128 85 35 1.1k
Leah Cuthbertson United Kingdom 17 557 0.8× 526 1.1× 289 1.6× 236 1.8× 224 2.6× 30 1.1k
Catherine Doherty United Kingdom 18 1.2k 1.7× 468 1.0× 242 1.3× 66 0.5× 82 1.0× 26 1.7k
Mary P. Carroll United Kingdom 24 1.1k 1.6× 842 1.8× 292 1.6× 259 2.0× 164 1.9× 39 1.8k
Simon Finch United Kingdom 19 1.3k 1.9× 191 0.4× 374 2.1× 220 1.7× 65 0.8× 55 1.7k
Margaret F. Guill United States 16 821 1.2× 323 0.7× 155 0.9× 141 1.1× 72 0.8× 39 1.3k
Douglas B. Hornick United States 19 465 0.7× 265 0.6× 287 1.6× 31 0.2× 124 1.5× 36 1.1k
David J. Serisier Australia 20 1.6k 2.5× 544 1.1× 544 3.0× 349 2.7× 150 1.8× 49 2.1k
G. Döering Germany 8 490 0.7× 266 0.6× 169 0.9× 68 0.5× 49 0.6× 14 630
Petra Schelstraete Belgium 18 426 0.6× 178 0.4× 174 1.0× 28 0.2× 139 1.6× 53 809
Pei Yee Tiew Singapore 16 417 0.6× 222 0.5× 157 0.9× 98 0.8× 141 1.7× 39 717

Countries citing papers authored by T. Daniels

Since Specialization
Citations

This map shows the geographic impact of T. Daniels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Daniels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Daniels more than expected).

Fields of papers citing papers by T. Daniels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Daniels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Daniels. The network helps show where T. Daniels may publish in the future.

Co-authorship network of co-authors of T. Daniels

This figure shows the co-authorship network connecting the top 25 collaborators of T. Daniels. A scholar is included among the top collaborators of T. Daniels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Daniels. T. Daniels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shepherd, Anthony I., Jo Corbett, Maria Perissiou, et al.. (2025). Cardiovascular function in people with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: A cross-sectional, observational, single-centre study. Journal of Cystic Fibrosis. 24(4). 801–808. 1 indexed citations
2.
Shepherd, Anthony I., Jo Corbett, Mathieu Gruet, et al.. (2025). Peripheral Muscle Function and Body Composition in People With Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: A Cross‐Sectional Single‐Centre Study. Pediatric Pulmonology. 60(3). e71044–e71044.
3.
Holgate, Stephen T., et al.. (2024). Clearing the air: Assessing healthcare professionals' awareness of air pollution's health consequences. SHILAP Revista de lepidopterología. 11(2). 100130–100130.
4.
McKone, Edward F., Kathleen J. Ramos, Cecilia Chaparro, et al.. (2023). Position paper: Models of post-transplant care for individuals with cystic fibrosis. Journal of Cystic Fibrosis. 22(3). 374–380. 6 indexed citations
5.
Duckworth, Christopher, Francis Chmiel, Daniel Burns, et al.. (2021). Using explainable machine learning to characterise data drift and detect emergent health risks for emergency department admissions during COVID-19. Scientific Reports. 11(1). 23017–23017. 59 indexed citations
6.
Chmiel, Francis, Daniel Burns, Florina Borca, et al.. (2021). Using explainable machine learning to identify patients at risk of reattendance at discharge from emergency departments. Scientific Reports. 11(1). 21513–21513. 15 indexed citations
7.
Shute, Janis K., Michael H. Cummings, Anthony I. Shepherd, et al.. (2020). Circulating biomarkers of antioxidant status and oxidative stress in people with cystic fibrosis: A systematic review and meta-analysis. Redox Biology. 32. 101436–101436. 36 indexed citations
8.
Shute, Janis K., Michael H. Cummings, Anthony I. Shepherd, et al.. (2019). The implications of dysglycaemia on aerobic exercise and ventilatory function in cystic fibrosis. Journal of Cystic Fibrosis. 19(3). 427–433. 7 indexed citations
9.
Daniels, T.. (2015). APPLICABILITY OF COLD METAL TRANSFER FOR REPAIR OF DISSIMILAR METAL WELDS IN STAINLESS STEEL PIPING IN NUCLEAR POWER PLANTS. OhioLink ETD Center (Ohio Library and Information Network). 3 indexed citations
10.
Daniels, T., et al.. (2015). CHARACTERISATION OF THE BONE HEALTH STATUS BY DEXA SCANNING OF ADULT CF PATIENTS ATTENDING A REGIONAL UK CENTRE. Pediatric Pulmonology. 50. 416–416. 1 indexed citations
11.
Cuthbertson, Leah, Geraint B. Rogers, Alan W. Walker, et al.. (2015). Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention. The ISME Journal. 10(5). 1081–1091. 84 indexed citations
12.
Daniels, T., et al.. (2014). Tibial bone versican content decreases with zoledronate treatment in adult mice. Osteoporosis International. 25(7). 1975–1981. 3 indexed citations
13.
Barry, Peter, Barry J. Plant, Arjun Nair, et al.. (2014). Effects of Ivacaftor in Patients With Cystic Fibrosis Who Carry the G551D Mutation and Have Severe Lung Disease. CHEST Journal. 146(1). 152–158. 77 indexed citations
14.
Cathie, Katrina, R. P. Howlin, Mary Carroll, et al.. (2014). G385 RATNO - Reducing Antibiotic Tolerance using Nitric Oxide in Cystic Fibrosis: report of a proof of concept clinical trial. Archives of Disease in Childhood. 99(Suppl 1). A159–A159. 7 indexed citations
15.
Daniels, T., Geraint B. Rogers, Franziska A. Stressmann, et al.. (2012). Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis. Journal of Cystic Fibrosis. 12(1). 22–28. 50 indexed citations
16.
Stressmann, Franziska A., Geraint B. Rogers, Chris Gast, et al.. (2012). Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience. Thorax. 67(10). 867–873. 117 indexed citations
17.
Stressmann, Franziska A., Geraint B. Rogers, Peter Marsh, et al.. (2011). Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?. Journal of Cystic Fibrosis. 10(5). 357–365. 102 indexed citations
18.
Howlin, R. P., Katrina Cathie, Luanne Hall‐Stoodley, et al.. (2011). Nitric oxide-mediated dispersal and enhanced antibiotic sensitivity in pseudomonas aeruginosa biofilms from the cystic fibrosis lung. Archives of Disease in Childhood. 96(Supplement 1). A45–A45. 4 indexed citations
19.
Rogers, Geraint B., Lucas R. Hoffman, Marvin Whiteley, et al.. (2010). Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy. Trends in Microbiology. 18(8). 357–364. 59 indexed citations
20.
Rogers, Geraint B., Franziska A. Stressmann, Garrit Koller, et al.. (2008). Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections. Diagnostic Microbiology and Infectious Disease. 62(2). 133–141. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026